New Therapy Could Have Worldwide Impact A team of researchers led by Dr. A. Kappas of The Rockefeller University has developed a new drug that effectively controls the development of jaundice in preterm newborns. The drug, called SnMP, blocks the production of bilirubin, the yellow pigment that l...